Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg-Negative Patients.

× No keyword cloud information.

10 in total

Review 1. Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift.

Authors: Yun-Fan Liaw
Journal: Hepatol Int Date: 2019-09-26 Impact factor: 6.047

2. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients.

Authors: Jia-Horng Kao; Tung-Hung Su; Wen-Juei Jeng; Qin Ning; Tai-Chung Tseng; Yoshiyuki Ueno; Man-Fung Yuen
Journal: Hepatol Int Date: 2021-07-23 Impact factor: 6.047

Review 3. Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection.

Authors: Yun-Fan Liaw
Journal: Nat Rev Gastroenterol Hepatol Date: 2019-09-02 Impact factor: 46.802

Review 4. Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors: Emilia Hadziyannis; Andreas Laras
Journal: Genes (Basel) Date: 2018-09-27 Impact factor: 4.096

Review 5. Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg-Negative Chronic Hepatitis B.

Authors: Florian van Bömmel; Thomas Berg
Journal: Hepatol Commun Date: 2021-06-18

6. Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up.

Authors: Apichat Kaewdech; Suraphon Assawasuwannakit; Pimsiri Sripongpun; Naichaya Chamroonkul; Pisit Tangkijvanich; Teerha Piratvisuth
Journal: Front Med (Lausanne) Date: 2022-03-24

Review 7. Current Trend in Antiviral Therapy for Chronic Hepatitis B.

Authors: Rong-Nan Chien; Yun-Fan Liaw
Journal: Viruses Date: 2022-02-21 Impact factor: 5.048

Review 8. Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus.

Authors: Teresa Broquetas; José A Carrión
Journal: Hepat Med Date: 2022-07-29

9. Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment.

Authors: Te-Ling Ma; Tsung-Hui Hu; Chao-Hung Hung; Jing-Houng Wang; Sheng-Nan Lu; Chien-Hung Chen
Journal: PLoS One Date: 2019-10-04 Impact factor: 3.240

10. Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.

Authors: Mao-Bing Chen; Hua Wang; Qi-Han Zheng; Xu-Wen Zheng; Jin-Nuo Fan; Yun-Long Ding; Jia-Li Niu
Journal: PLoS One Date: 2019-11-21 Impact factor: 3.240

10 in total